Skip Navigation


Carcinogenesis Advance Access originally published online on September 30, 2004
Carcinogenesis 2005 26(4):703-711; doi:10.1093/carcin/bgh293
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Supplementary Material
Right arrow All Versions of this Article:
26/4/703    most recent
bgh293v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (33)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Behbod, F.
Right arrow Articles by Rosen, J. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Behbod, F.
Right arrow Articles by Rosen, J. M.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Carcinogenesis vol.26 no.4 © Oxford University Press 2004; all rights reserved.

REVIEW

Will cancer stem cells provide new therapeutic targets?

Fariba Behbod and Jeffrey M. Rosen*

Department of Molecular and Cellular Biology, Baylor College of Medicine, One Baylor Plaza, Houston, TX 77030-3498, USA

* To whom correspondence should be addressed. Tel: +1 713 798 6210; Fax: +1 713 798 8012; Email: jrosen{at}bcm.tmc.edu

This review presents a brief synopsis of recent progress in the area of cancer stem cells, with emphasis on leukemia and breast cancer, and discusses potential limitations to accomplishing the ultimate goal of eradicating residual disease in cancer.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 CarcinogenesisHome page
L. Melchor and J. Benitez
An integrative hypothesis about the origin and development of sporadic and familial breast cancer subtypes
Carcinogenesis, August 1, 2008; 29(8): 1475 - 1482.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
K. Pilbeam, P. Basse, L. Brossay, N. Vujanovic, R. Gerstein, A. N. Vallejo, and L. Borghesi
The Ontogeny and Fate of NK Cells Marked by Permanent DNA Rearrangements
J. Immunol., February 1, 2008; 180(3): 1432 - 1441.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
S. Lopez-Tarruella and R. Schiff
The Dynamics of Estrogen Receptor Status in Breast Cancer: Re-shaping the Paradigm
Clin. Cancer Res., December 1, 2007; 13(23): 6921 - 6925.
[Full Text] [PDF]

Home page
 J. Cell Biol.Home page
R. Villadsen, A. J. Fridriksdottir, L. Ronnov-Jessen, T. Gudjonsson, F. Rank, M. A. LaBarge, M. J. Bissell, and O. W. Petersen
Evidence for a stem cell hierarchy in the adult human breast
J. Cell Biol., April 9, 2007; 177(1): 87 - 101.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
W. A. Woodward, M. S. Chen, F. Behbod, M. P. Alfaro, T. A. Buchholz, and J. M. Rosen
WNT/beta-catenin mediates radiation resistance of mouse mammary progenitor cells
PNAS, January 9, 2007; 104(2): 618 - 623.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
C. T. Jordan, M. L. Guzman, and M. Noble
Cancer stem cells.
N. Engl. J. Med., September 21, 2006; 355(12): 1253 - 1261.
[Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
T. Okumura, S. Tsunoda, Y. Mori, T. Ito, K. Kikuchi, T. C. Wang, S. Yasumoto, and Y. Shimada
The Biological Role of the Low-Affinity p75 Neurotrophin Receptor in Esophageal Squamous Cell Carcinoma
Clin. Cancer Res., September 1, 2006; 12(17): 5096 - 5103.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
P. P. Szotek, R. Pieretti-Vanmarcke, P. T. Masiakos, D. M. Dinulescu, D. Connolly, R. Foster, D. Dombkowski, F. Preffer, D. T. MacLaughlin, and P. K. Donahoe
Ovarian cancer side population defines cells with stem cell-like characteristics and Mullerian Inhibiting Substance responsiveness
PNAS, July 25, 2006; 103(30): 11154 - 11159.
[Abstract] [Full Text] [PDF]


Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.